|
Stephen Kevin Burley is a British-born scientist, naturalized in both Canada and the United States, specializing in oncology and structural biology. He is a Distinguished Professor in the Department of Chemistry and Chemical Biology at Rutgers University. Burley directs the RCSB Protein Data Bank (a member of the Worldwide Protein Data Bank) and the Center for Integrative Proteomics Research ==Career== Burley has a Bachelor in physics from the University of Western Ontario〔http://www.prnewswire.com/news-releases/structural-genomix-appoints-stephen-k-burley-as-chief-scientific-officer-73660352.html〕 and is D.Phil from Oxford University, England in Molecular Biophysics as a Rhodes scholar.〔http://chem.rutgers.edu/introducing-professor-stephen-k-burley〕 Burley has an M.D. from Harvard Medical School. He worked with Gregory A. Petsko and William N. Lipscomb at MIT and Harvard. He was faculty at Howard Hughes Medical Institute and Rockefeller University. Burley co-founded Prospect Genomics, Inc,〔http://investing.businessweek.com/research/stocks/people/person.asp?personId=1450433&ticker=ONTY&previousCapId=31973&previousTitle=NESTLE%20SA-REG〕 a computational genomics pharma. He was Chief Scientific Officer of SGX Pharmaceuticals after it acquired Prospect. SGX was in turn merged with Eli Lilly in 2008 where Burley was a Distinguished Lilly Research Scholar in Lilly Research Laboratories〔http://proteomics.rutgers.edu/public/?q=faculty/burley〕 In 2012 Burley joined Rutgers 〔http://www.njbiz.com/article/20121217/NJBIZ01/121219761/Rutgers-recruits-top-researcher-to-head-Center-for-Integrative-Proteomics-Research〕 as Director of the Center for Integrative Proteomics Research and became director of the PDB in 2014, succeeding Prof. Helen Berman〔http://www.rcsb.org/pdb/explore/news.do?p=general_information/news_publications/news#201407151450〕 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Stephen K. Burley」の詳細全文を読む スポンサード リンク
|